Close Menu
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    Subscribe
    Home»BioTech»Avantor Named Best Bioprocessing Supplier in Single-Use Manufacturing at Asia-Pacific Bioprocessing Excellence Awards 2021
    BioTech

    Avantor Named Best Bioprocessing Supplier in Single-Use Manufacturing at Asia-Pacific Bioprocessing Excellence Awards 2021

    Business News AsiaBy Business News AsiaApril 6, 2021No Comments3 Mins Read
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Avantor Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, was named Best Bioprocessing Supplier in Single-Use Manufacturing at the Asia-Pacific Bioprocessing Excellence Awards 2021 held recently.

    The award recognizes Avantor’s contributions in facilitating biomanufacturing excellence with enhanced speed, reduced cost and superior quality, and reaffirms its critical role in biomanufacturing of biologics. Avantor was also awarded Best Company in Bioprocessing Excellence for Single-use Solutions at Biologics Manufacturing Korea 2020.

    Narayana Rao Rapolu, Vice President, Biopharma Asia Middle East & Africa for the Company said, “Avantor has long been an open-architecture, single-use provider, offering complete design, manufacturing and logistics to support every stage of the biomanufacturing process. Our work in biopharma has never been more important. From the small-scale bench, to pilot plant and full commercial manufacturing, we enable our customers to reach the market with new treatments for patients – faster, safer and smarter.”

    Significance of single-use technologies:
    – Robust and scalable, enabling transformative treatments to reach more patients globally.
    – According to BioPharm International, a publication that integrates the science and business of biopharmaceuticals, single-use technologies are used in nearly 85% of pre-commercial manufacturing of biologics.
    – Applications of biologics include monoclonal antibodies (mAbs) used in therapeutic solutions for immune-oncology and immunotherapy and cell and gene therapies which help to treat challenging illnesses, such as some cancers and genetic diseases.

    For more information about Avantor’s single-use solutions for biopharma manufacturing, watch this video: https://youtu.be/mfjZEfO_RVM.

    About Avantor

    Avantor, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. One of our greatest strengths comes from having a global infrastructure that is strategically located to support the needs of our customers. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world.

    For information, visit avantorsciences.com and find us on:
    LinkedIn: https://www.linkedin.com/company/avantorinc/
    Twitter: https://twitter.com/Avantor_News
    Facebook: https://www.facebook.com/Avantorinc/

    About Asia-Pacific Bioprocessing Excellence Award 2021 (ABEA)

    The Asia-Pacific Bioprocessing Excellence Awards seeks to give recognition to exceptional bioprocessing experts, organizations and technologies that facilitate biomanufacturing excellence with enhanced speed, reduced cost, and superior quality. 2021 marks the fifth year of ABEA, which was first established in 2017 and backed by industry requests.

    AMEA Media Contact
    Christina Koh
    Director – Communications, AMEA
    Avantor
    Phone: +65 9170 0169
    Email: Christina.Koh@avantorsciences.com

    Source: Avantor and Financial News

    ABEA Asia-Pacific Bioprocessing Excellence Award 2021 Asiapacific Avantor BioPharm Bioprocessing
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleVolcano IPO Debut Sees Jump of 100% to 70 sen on ACE Market
    Next Article Ni Hsin to Expand Energy Coffee Business through Partnership with O&G Cooperative

    Related Posts

    CanSinoBIO Reports Growth in First Nine Months: Commercialization Accelerates Across Multiple Products as Platform Innovation Opens New Avenues for Growth

    October 27, 2026

    Hengrui Pharma Reports Steady Growth in the First Nine Months of 2026

    October 27, 2026

    Micot Pharma Showcases First-in-Class, Brain-Penetrant TrkB Agonist MT200605 at World Stroke Congress, Building the Case for Global Partnerships and Commercialization

    October 27, 2026
    Add A Comment

    Comments are closed.

    Latest News

    • Garuda Indonesia Advances Digital Transformation, Expands Travel Flexibility with Upgraded Manage My Booking Service
    • Chervon Launches Advanced Momentum Program (AMP) to Hire & Develop the Next Generation of Leaders
    • Autumn Lighting Fair, Outdoor and Tech Light Expo, Eco Expo Asia draw some 62,000 buyers
    • OMRON Healthcare Begins Full-Scale Production at First Factory in India
    • Rasa Light Je: Spritzer Sparkling Invites Malaysians to Go Light on Themselves with a Positive Approach to Everyday Wellbeing
    • Garuda Indonesia Group’s Transformation Programme Drives 13.2% Revenue Growth to US$2.71 Billion Amid High Jet Fuel Prices
    • CIMC Group Announces Results for the First Three Quarters of 2026
    • TANAKA MIRAI Lab., JAF MEDIA WORKS, and Della Begin Joint Research to Visualize Drivers’ Conditions through Analysis of Sweat Components
    • U.S. Polo Assn. Executes Early on Europe’s Digital Product Passport Mandate
    • COSCO SHIPPING Ports Announces 2026 Third Quarter Results
    © 2026 BusinessNewsAsia.com

    Type above and press Enter to search. Press Esc to cancel.